Takeda Pharmaceutical Co Ltd (TKPHF) Change in Intangibles (2018 - 2026)

Takeda Pharmaceutical's Change in Intangibles history runs 9 years deep, the most recent figure standing at -$310.1 million for Q2 2026.

• In Q2 2026, Change in Intangibles fell 65.23% year-over-year to -$310.1 million; the TTM figure through Jun 2026 stood at -$119.9 million (down 116.76% YoY), while the FY2026 annual figure was $5.8 million, down 98.46% from the prior year.
• Change in Intangibles for Q2 2026 stood at -$310.1 million, down from $1.3 million in the prior quarter.
• The five-year high for Change in Intangibles was $1.1 billion in Q1 2025, with the low at -$3.1 billion in Q1 2023.
• The 5-year median for Change in Intangibles is -$139.8 million (2022), against an average of -$351.5 million.
• The sharpest annual moves came in 2023 and 2025: Change in Intangibles tumbled 2108.38% in 2023, then soared 889.3% in 2025.
• Takeda Pharmaceutical's Change in Intangibles stood at -$121.5 million in 2022, then sank by 67.35% to -$203.3 million in 2023, then surged by 62.58% to -$76.1 million in 2024, then soared by 101.66% to $1.3 million in 2025, then tumbled by 24698.56% to -$310.1 million in 2026.
• Business Quant data shows TKPHF's Change in Intangibles at -$310.1 million in Q2 2026, $1.3 million in Q4 2025, and $189.0 million in Q3 2025.